Dimepregnen

This classification denotes a therapeutic progestin with the molecular formula C23H36O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X08N6BOT8Y, chemically known as 3beta-hydroxy-6alpha,16alpha-di-methylpregn-4-en-20-one. but generally known as dimepregnen, which bears US NIH Compound Identifier 208839. European Medicines Agency schedules Dimepregnen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07163MIG. The term DIMEPREGNEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). DIMEPREGNEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dimepregnen under HS 29144090 and SITC 51629. As of Q4 2014, DIMEPREGNEN remains the US FDA Preferred Term for this commodity. Dimepregnen bears US NLM identifiers UMLS ID C1880333 and NCI Concept Code C65401. SMILES: O=C(C1C2(C(C3C(C4(C(=CC(O)CC4)C(C3)C)C)CC2)CC1C)C)C.